Inventor · disambiguated record
Kristian Ruepp
Also filed as: RUEPP KRISTIAN
5 granted patents·35 citations·filing 2013–2020
80Inventor score
Top patents by PatentIndex Score
5 records- 0193US9119786B2Crystalline N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mono mesylate monohydrate having a specific particle size distribution range and a specific surface area range for use in pharmaceutical formulationsAICURIS GMBH & CO KG·Filed 2013·Granted Sep 1, 2015·15 cites·19 claims
- 0292US10137117B2Crystalline N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2[4-(2-pyridinyl)phenyl]acetamide mono mesylate monohydrate having a specific particle size distribution range and a specific surface area range for use in pharmaceutical formulationsAICURIS ANTI INFECTIVE CURES GMBH·Filed 2017·Granted Nov 27, 2018·6 cites·22 claims
- 0392US9592225B2Crystalline N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mono mesylate monohydrate having a specific particle size distribution range and a specific surface area range for use in pharmaceutical formulationsAICURIS ANTI-INFECTIVE CURES GMBH·Filed 2015·Granted Mar 14, 2017·8 cites·22 claims
- 0491US9889124B2Crystalline N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mono mesylate monohydrate having a specific particle size distribution range and a specific surface area range for use in pharmaceutical formulationsAICURIS ANTI INFECTIVE CURES GMBH·Filed 2015·Granted Feb 13, 2018·6 cites·30 claims
- 0572USRE49697ECrystalline N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mono mesylate monohydrate having a specific particle size distribution range and a specific surface area range for use in pharmaceutical formulationsAICURIS ANTI INFECTIVE CURES GMBH·Filed 2020·Granted Oct 17, 2023·0 cites·32 claims
Join the waitlist — get patent alerts
Get an alert when Kristian Ruepp files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →